Gilead Sciences Teams With Novo Nordisk for Trials of Liver Disease Drugs

Biotech company Gilead Sciences (GILD - Get Report) will team up with Danish healthcare company Novo Nordisk (NVO - Get Report) in their efforts to help combat liver disease.

The two companies said they will collaborate on clinical trials for medications for treating nonalcoholic steatohepatitis (NASH).